We do believe the issues cited were very minor, and I think the fine is probably an indication of the view of severity.
Wendel Barr
The view was that the contact probably was not warranted.
view
issues view
This investment will allow us to meet our clients' growing demand for high-science, first-in-human clinical trial services and address one of their toughest drug development challenges.
trial growing challenges development demand investment
You must log in to post a comment.
There are no comments yet.